Abstract

CURRENT ISSUES REGARDING APPROVED PEPTIDE AND PROTEIN DRUGS IN BULGARIA

Silvia Mihaylova*, A. Tsvetkova, M. Arnaoudova, A. Todorova, V. Petkova, M. Dimitrov, M. Manova and Al. Savova

ABSTRACT

Peptide drugs have received a considerable amount of attention by various researchers over last years. Innovations in the health and pharmaceutical sectors are interpreted as a transformation of the potential scientific and technical progress into a real one, by creating new medical products and health services. The development of peptide products is associated with the achievement of both good business results and provision of new products for more efficient treatment and better therapeutic status.

Keywords: Peptides, pharmaceutical market, FDA, EMA, BDA.